| Assay ID | Title | Year | Journal | Article |
|---|
| AID1277343 | Inhibition of human ABCC1 transfected in MDCK2 cells assessed as potentiation of doxorubicin-induced cytotoxicity at 1 and 5 uM by crystal violet staining based assay | 2016 | European journal of medicinal chemistry, Feb-15, Volume: 109 | Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. |
| AID1168902 | Modulation of P-gp mediated drug efflux in human MES-SA cells assessed as accumulation of rhodamine-123 incubated for 15 mins prior to rhodamine-123 addition measured after 1 hr by fluorescence analysis | 2014 | Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
| Thieno[2,3-b]pyridines--a new class of multidrug resistance (MDR) modulators. |
| AID1277333 | Inhibition of ABCG2 in human MCF7/Topo cells by Hoechst 33342 assay | 2016 | European journal of medicinal chemistry, Feb-15, Volume: 109 | Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. |
| AID1277339 | Cytotoxicity against human ABCC1 transfected MDCK2 cells assessed as reduction in cell proliferation at 10 uM by crystal violet staining based assay | 2016 | European journal of medicinal chemistry, Feb-15, Volume: 109 | Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. |
| AID1277342 | Inhibition of human ABCC1 transfected in MDCK2 cells assessed as potentiation of etoposide-induced cytotoxicity at 1 and 5 uM by crystal violet staining based assay | 2016 | European journal of medicinal chemistry, Feb-15, Volume: 109 | Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. |
| AID1277331 | Inhibition of human MRP1 transfected in MDCK2 cells assessed as inhibition of calcein-AM efflux | 2016 | European journal of medicinal chemistry, Feb-15, Volume: 109 | Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. |
| AID1168903 | Modulation of MRP1 mediated drug efflux in doxorubicin-resistant human H69 cells assessed as accumulation of calcein AM incubated for 15 mins prior to calcein AM addition measured after 30 mins by fluorescence analysis | 2014 | Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
| Thieno[2,3-b]pyridines--a new class of multidrug resistance (MDR) modulators. |
| AID1168906 | Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by neutral red dye-based assay | 2014 | Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
| Thieno[2,3-b]pyridines--a new class of multidrug resistance (MDR) modulators. |
| AID1277335 | Inhibition of ABCB1 in human KBV1 cells assessed as inhibition of calcein-AM efflux at 1 uM relative to tariquidar | 2016 | European journal of medicinal chemistry, Feb-15, Volume: 109 | Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. |
| AID1277332 | Inhibition of ABCB1 in human KBV1 cells assessed as inhibition of calcein-AM efflux | 2016 | European journal of medicinal chemistry, Feb-15, Volume: 109 | Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization. |
| AID1168905 | Antagonist activity at calcium channel in rat A7R5 cells assessed as inhibition of Cacl2/KCl-induced increase in intracellular Ca2+ incubated for 15 mins prior to Cacl2/KCl challenge by fluorescence assay | 2014 | Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
| Thieno[2,3-b]pyridines--a new class of multidrug resistance (MDR) modulators. |
| AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |